Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Inamoto

Showing results (51-60 of 123) with videos related to

Pageof 13
Sort By:
Nihon Gan Chiryo Gakkai Shi|June 20, 1985
[The cytotoxic activity of tumor infiltrating lymphocytes (TIL) and its application to adoptive immunotherapy]T Hori, N Kan, N Yamasaki, et al.
Breast Cancer (Tokyo, Japan)|May 9, 2001
Results of breast-conserving therapy for ductal carcinoma in situ: the Kyoto University experiencesM Kokubo, M Mitsumori, K Kanehira, et al.
Nihon Gan Chiryo Gakkai Shi|April 20, 1985
[The oral administration of OK-432. The 5th report: the effects on the lymphoproliferative response and natural killer cell activity in mice with transplanted cecal tumors]Y Nio, T Inamoto, T Hori, et al.
International Immunology|June 1, 1995
Suppression of adult T cell leukemia-derived factor/human thioredoxin induction by FK506 and cyclosporin A: a new mechanism of immune modulation via redox controlK Furuke, H Nakamura, T Hori, et al.
Transplantation|December 1, 1992
An increase in spontaneous proliferation of peripheral blood mononuclear cells in the early phase after liver transplantation--a useful indication of acute rejectionH Kato, T Inamoto, S Uyama, et al.
Nihon Gan Chiryo Gakkai Shi|February 20, 1985
[Adoptive immunotherapy of murine tumor using cultured syngeneic tumor-bearer-spleen cells. 1: Anti-tumor activity of tumor-bearer-spleen cells cultured with T cell growth factor (TCGF) and soluble tumor extract]N Kan, T Inamoto, N Yamasaki, et al.
Nihon Geka Hokan. Archiv Fur Japanische Chirurgie|January 1, 1984
[Experimental and clinical evaluation of small peptides as a nitrogen source in enteral nutrition (II). Clinical application of T-330 and a comparative study with Elental]N Kobayashi, H Tanimura, T Inamoto, et al.
Nihon Geka Gakkai Zasshi|January 1, 1985
[An in vitro sensitivity assay of anti-cancer agents by measuring the inhibition rate of DNA synthesis (3H-thymidine uptake) of cancer cells--clinical study]Y Nio, T Inamoto, K Ohgaki, et al.
Nihon Geka Hokan. Archiv Fur Japanische Chirurgie|November 1, 1983
Cancer immunotherapy by local transfer of autologous T lymphocytes cultured with T cell growth factor and autologous tumor extract: a clinical trialN Kan, K Ohgaki, N Yamasaki, et al.
Nihon Gan Chiryo Gakkai Shi|May 20, 1985
[Adoptive immunotherapy of murine tumors using cultured syngeneic tumor-bearer-spleen cells. II: Therapeutic effect of cultured lymphocytes against malignant ascites and its augmentation by the streptococcal preparation, OK 432]N Kan, T Inamoto, T Hori, et al.
Pageof 13

Showing results (51-60 of 123) with videos related to

Sort By:
Pageof 13
Nihon Gan Chiryo Gakkai Shi|June 20, 1985
[The cytotoxic activity of tumor infiltrating lymphocytes (TIL) and its application to adoptive immunotherapy]T Hori, N Kan, N Yamasaki, et al.
Breast Cancer (Tokyo, Japan)|May 9, 2001
Results of breast-conserving therapy for ductal carcinoma in situ: the Kyoto University experiencesM Kokubo, M Mitsumori, K Kanehira, et al.
Nihon Gan Chiryo Gakkai Shi|April 20, 1985
[The oral administration of OK-432. The 5th report: the effects on the lymphoproliferative response and natural killer cell activity in mice with transplanted cecal tumors]Y Nio, T Inamoto, T Hori, et al.
International Immunology|June 1, 1995
Suppression of adult T cell leukemia-derived factor/human thioredoxin induction by FK506 and cyclosporin A: a new mechanism of immune modulation via redox controlK Furuke, H Nakamura, T Hori, et al.
Transplantation|December 1, 1992
An increase in spontaneous proliferation of peripheral blood mononuclear cells in the early phase after liver transplantation--a useful indication of acute rejectionH Kato, T Inamoto, S Uyama, et al.
Nihon Gan Chiryo Gakkai Shi|February 20, 1985
[Adoptive immunotherapy of murine tumor using cultured syngeneic tumor-bearer-spleen cells. 1: Anti-tumor activity of tumor-bearer-spleen cells cultured with T cell growth factor (TCGF) and soluble tumor extract]N Kan, T Inamoto, N Yamasaki, et al.
Nihon Geka Hokan. Archiv Fur Japanische Chirurgie|January 1, 1984
[Experimental and clinical evaluation of small peptides as a nitrogen source in enteral nutrition (II). Clinical application of T-330 and a comparative study with Elental]N Kobayashi, H Tanimura, T Inamoto, et al.
Nihon Geka Gakkai Zasshi|January 1, 1985
[An in vitro sensitivity assay of anti-cancer agents by measuring the inhibition rate of DNA synthesis (3H-thymidine uptake) of cancer cells--clinical study]Y Nio, T Inamoto, K Ohgaki, et al.
Nihon Geka Hokan. Archiv Fur Japanische Chirurgie|November 1, 1983
Cancer immunotherapy by local transfer of autologous T lymphocytes cultured with T cell growth factor and autologous tumor extract: a clinical trialN Kan, K Ohgaki, N Yamasaki, et al.
Nihon Gan Chiryo Gakkai Shi|May 20, 1985
[Adoptive immunotherapy of murine tumors using cultured syngeneic tumor-bearer-spleen cells. II: Therapeutic effect of cultured lymphocytes against malignant ascites and its augmentation by the streptococcal preparation, OK 432]N Kan, T Inamoto, T Hori, et al.
Pageof 13